"Australia has some of the basic building blocks, including an “abundance of world class universities and an abundance of world class intellectual property. It also has an abundance of CROs (contract research organisations) to develop late stage assets. What we don’t have is the piece in the middle which is the preclinical experience to develop these early stage assets and the investors to fund it.”Proto Axiom is set to announce its first major investment with a second expected early next year....Read the articlehttps://www.theaustralian.com.au/business/backing-biotechs-with-usstyle-entrepreneurialism/news-story/4b5b76f83fcd2e1fa2ed00d5d84f0bd8...About Proto Axiom 
Scientists at CSIRO (Australia's Government Science & Industrial Research Organisation) are developing a machine learning tool which provides an
early warning to medical professionals of a patient’s deteriorating
condition.
The study, published in Nature: Scientific Reports, showed the early warning
deterioration alerts can be set to monitor patients two to eight hours before
they are triggered by current clinical criteria. CSIRO's Dr Dr Sankalp Khanna says, 'Until now there hasn’t been a way to harness all the
data to predict patient health. This new tool has the potential to
transform the day-to-day functioning of health systems'.